PolyPeptide Group AG (SWX: PPGN)
Switzerland
· Delayed Price · Currency is CHF 29.25
+0.85 (2.99%)
Jan 3, 2025, 5:31 PM CET
PolyPeptide Group AG Market Cap
PolyPeptide Group AG has a market cap or net worth of 964.77 million as of January 3, 2025. Its market cap has increased by 78.03% in one year.
Market Cap
964.77M
Enterprise Value
1.03B
Revenue
311.55M
Ranking
n/a
PE Ratio
n/a
Stock Price
29.25
Market Cap Chart
Since April 29, 2021, PolyPeptide Group AG's market cap has decreased from 2.59B to 964.77M, a decrease of -62.76%. That is a compound annual growth rate of -23.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 3, 2025 | 964.77M | 2.99% |
| Dec 30, 2024 | 936.73M | 62.30% |
| Dec 29, 2023 | 577.18M | -30.79% |
| Dec 30, 2022 | 833.98M | -81.57% |
| Dec 30, 2021 | 4.53B | 74.70% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 205.19B |
| Novartis AG | 177.34B |
| Lonza Group AG | 38.70B |
| Alcon | 38.03B |
| Galderma Group AG | 23.91B |
| Straumann Holding AG | 18.22B |
| Sonova Holding AG | 17.66B |
| Sandoz Group AG | 16.31B |